A Study Evaluating the Effect of Pembrolizumab (MK-3475) in Participants With Renal Cell Cancer (MK-3475-031)
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Capacity of the Dual Combination Raltegravir/Etravirine to Maintain Virological Success in HIV-1 Infected Patients of at Least 45 Years of Age- ANRS 163 ETRAL
- Status
- COMPLETED
- Phase
- PHASE2
Raltegravir-based Antiretroviral Versus Maintaining Any Other Antiretroviral Therapy in HIV Mono-infected Patients
- Status
- COMPLETED
- Phase
- PHASE4
GnRHa Trigger in Asian Oocyte Donors- a Dose Finding Study
- Status
- COMPLETED
- Phase
- NA
Grazoprevir (MK-5172)/Elbasvir (MK-8742) Versus Boceprevir/Pegylated Interferon/Ribavarin for Chronic Hepatitis C Infection (MK-5172-066)
- Status
- WITHDRAWN
- Phase
- PHASE3
Study of Grazoprevir (MK-5172) and Elbasvir (MK-8742) in Japanese Participants With Chronic Hepatitis C (MK-5172-058)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Telemonitoring System Study in Participants With Type 2 Diabetes Mellitus (MK-0000-347)
- Status
- COMPLETED
- Phase
- NA
Randomized, Controlled Single-blind Clinical Study to Assess Vaccine Interchangeability Between RV5 and RV1 Using Seven Combined Anti-rotavirus Prevention Programs
- Status
- COMPLETED
- Phase
- PHASE3
Effects of Deep Neuromuscular Blockade on Intraoperative Respiratory Mechanics
- Status
- COMPLETED
- Phase
- PHASE4
Olaparib in gBRCA Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Elpipodect (MK-8189) Multiple Dose Study in Healthy Volunteers and Schizophrenia Participants (MK-8189-003)
- Status
- COMPLETED
- Phase
- PHASE1
A Lot-to-Lot Consistency Study to Evaluate Safety, Tolerability, and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Healthy Adults (V212-014)
- Status
- WITHDRAWN
- Phase
- PHASE3
Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Pembrolizumab (MK-3475) in Participants With Advanced Melanoma (MK-3475-041/KEYNOTE-041)
- Status
- COMPLETED
- Phase
- PHASE1
A Study Of 4-1BB Agonist PF-05082566 Plus PD-1 Inhibitor MK-3475 In Patients With Solid Tumors (B1641003/KEYNOTE-0036)
- Status
- COMPLETED
- Phase
- PHASE1
Empowerment and Support for the Diabetic Patient
- Status
- UNKNOWN
- Phase
- NA
Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Evaluation of Safety, Tolerability, Pharmacokinetics, and Antiretroviral Activity of Ulonivirine (MK-8507) in Human Immunodeficiency Virus (HIV-1)-Infected Participants (MK-8507-003)
- Status
- COMPLETED
- Phase
- PHASE1
Early Signs of Efficacy Study With Riociguat in Adult Homozygous Delta F508 Cystic Fibrosis Patients
- Status
- TERMINATED
- Phase
- PHASE2
4 Pillars Toolkit for Adolescent Vaccination
- Status
- COMPLETED
- Phase
- NA